RETATRUTIDE
US$ 26.16
glp-1 drugs addiction linked to lower rates in large study of veterans | Science GLP-1 and Addiction: Clinical Trials
Description
All-Day Comfort & Adhesion: Designed for continuous wear, the GLP-1 patch features an ultra-thin, breathable construction
156 WangG
Trapp S, Cork SC
Thus, all patients were followed from study cohort entry until one of the study outcomes (described below), treatment discontinuation, initiation of a study drug in the comparator group, death from any cause (depending on the outcome), end of registration, or the end of the study period (29 March 2021), whichever came first
Phase 2: early escalation (weeks 3 to 4) Concentration: 1mg/mL suspension
